BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6485015)

  • 21. Buthionine sulfoximine pretreatment potentiates the effect of isolated lung perfusion with doxorubicin.
    Port JL; Hochwald SN; Wang HY; Burt ME
    Ann Thorac Surg; 1995 Aug; 60(2):239-43; discussion 244. PubMed ID: 7544099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of modulators of glutathione synthesis on the hepatotoxicity of 2-methylfuran.
    Ravindranath V; Boyd MR
    Biochem Pharmacol; 1991 May; 41(9):1311-8. PubMed ID: 2018563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcellular glutathione contents in isolated hepatocytes treated with L-buthionine sulfoximine.
    Romero FJ; Sies H
    Biochem Biophys Res Commun; 1984 Sep; 123(3):1116-21. PubMed ID: 6487323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effect of cyanohydroxybutene on glutathione synthesis in liver and pancreas of male rats.
    Davis MA; Wallig MA; Eaton D; Borroz KI; Jeffery EH
    Toxicol Appl Pharmacol; 1993 Dec; 123(2):257-64. PubMed ID: 7902618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatotoxicity of eugenol in mice depleted of glutathione by treatment with DL-buthionine sulfoximine.
    Mizutani T; Satoh K; Nomura H; Nakanishi K
    Res Commun Chem Pathol Pharmacol; 1991 Feb; 71(2):219-30. PubMed ID: 2047567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of the acute toxicity of methyl chloride in male B6C3F1 mice by glutathione depletion.
    Chellman GJ; White RD; Norton RM; Bus JS
    Toxicol Appl Pharmacol; 1986 Oct; 86(1):93-104. PubMed ID: 3764938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of modulation of hepatic glutathione on biotransformation and covalent binding of aflatoxin B1 to DNA in the mouse.
    Monroe DH; Eaton DL
    Toxicol Appl Pharmacol; 1988 Jun; 94(1):118-27. PubMed ID: 3131927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of buthionine sulfoximine and cysteine on the hepatotoxicity of butylated hydroxytoluene in rats.
    Nakagawa Y
    Toxicol Lett; 1987 Aug; 37(3):251-6. PubMed ID: 3617099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-hypoxic effect of glutathione depletors.
    Masukawa T; Sai M; Tochino Y
    Life Sci; 1989; 44(5):311-8. PubMed ID: 2915602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enalapril hepatotoxicity in the rat. Effects of modulators of cytochrome P450 and glutathione.
    Jurima-Romet M; Huang HS
    Biochem Pharmacol; 1992 Nov; 44(9):1803-10. PubMed ID: 1449535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma glutathione turnover in the rat: effect of fasting and buthionine sulfoximine.
    Hum S; Robitaille L; Hoffer LJ
    Can J Physiol Pharmacol; 1991 May; 69(5):581-7. PubMed ID: 1863907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative hepatotoxicity and metabolism of N-methylformamide in rats and mice.
    Tulip K; Timbrell JA
    Arch Toxicol; 1988; 62(2-3):167-76. PubMed ID: 3196150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer.
    Berger SJ; Gosky D; Zborowska E; Willson JK; Berger NA
    Cancer Res; 1994 Aug; 54(15):4077-83. PubMed ID: 8033140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of buthionine sulfoximine on acute N-(3,5-dichlorophenyl)succinimide-induced nephrotoxicity in Fischer 344 rats.
    Rankin GO; Teets VJ; Nicoll DW; Brown PI
    Toxicol Lett; 1990 Jun; 52(1):91-100. PubMed ID: 2356574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of metallothionein synthesis by glutathione depletion after trans- and cis-stilbene oxide administration in rats.
    Sato M; Sasaki M; Oguro T; Kuroiwa Y; Yoshida T
    Chem Biol Interact; 1995 Oct; 98(1):15-25. PubMed ID: 7586048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promotion of trans-platinum in vivo effects on renal heme and hemoprotein metabolism by D,L-buthionine-S,R-sulfoximine. Possible role of glutathione.
    Mayer RD; Maines MD
    Biochem Pharmacol; 1990 May; 39(10):1565-71. PubMed ID: 2337413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of silica-induced lung injury by reducing lung non-protein sulfhydryls with buthionine sulfoximine.
    Lombard-Gillooly K; Hubbard AK
    Toxicol Lett; 1993 Mar; 66(3):305-15. PubMed ID: 8386403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of buthionine sulfoximine on the development of ozone-induced pulmonary fibrosis.
    Sun JD; Pickrell JA; Harkema JR; McLaughlin SI; Hahn FF; Henderson RF
    Exp Mol Pathol; 1988 Oct; 49(2):254-66. PubMed ID: 2901982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo production of different chloroform metabolites: effect of phenobarbital and buthionine sulfoximine pretreatment.
    Gemma S; Sbraccia M; Testai E; Vittozzi L
    Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):45-7. PubMed ID: 7698083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of buthionine sulfoximine and diethyl maleate on glutathione turnover in the channel catfish.
    Gallagher EP; Hasspieler BM; Di Giulio RT
    Biochem Pharmacol; 1992 May; 43(10):2209-15. PubMed ID: 1350905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.